Canada markets open in 6 hours 56 minutes

Zelira Therapeutics Limited (ZLDAF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.48000.0000 (0.00%)
At close: 01:07PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
2020-06-30
Total Revenue
301.121
301.121
1,541
432.568
-
Cost of Revenue
362.56
362.56
939.054
228.222
-
Gross Profit
-61.439
-61.439
601.57
204.346
-
Operating Expenses
Research Development
1,336
1,336
-
2,081
-
Selling General and Administrative
3,062
3,062
6,078
4,490
1,974
Total Operating Expenses
7,202
7,202
14,247
10,196
7,937
Operating Income or Loss
-7,263
-7,263
-13,645
-9,991
-7,937
Interest Expense
12.344
76.661
53.848
42.627
12.344
Total Other Income/Expenses Net
1,071
1,071
1,275
1,484
925.491
Income Before Tax
-6,269
-6,269
-12,414
-8,549
-7,015
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-6,269
-6,269
-12,414
-8,549
-7,015
Net Income
-5,573
-5,573
-11,945
-8,549
-7,015
Net Income available to common shareholders
-5,573
-5,573
-11,945
-8,549
-7,015
Basic EPS
-0.55
-0.55
-1.54
-1.28
-1.45
Diluted EPS
-0.55
-0.55
-1.54
-1.28
-1.45
Basic Average Shares
10,068
10,068
8,042
6,633
4,848
Diluted Average Shares
10,068
10,068
8,042
6,633
4,848